iOS
Android
Facebook
WhatsApp
Twitter
Dapazin is a highly potent, selective, and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that improves glycemic control in patients with type 2 diabetes mellitus by reducing renal glucose reabsorption leading to urinary excretion of excess glucose (glucuresis).
/ 5.0
KES 1,904.00
15 sold in the last 7 days
Delivery within 4 hours on all orders placed between 8:00 AM & 8:00 PM
